Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • drsnafu1831
    Junior Member
    • Dec 2016
    • 1

    #1

    TopHat (Tuxedo Suite) - AWS vs Local

    Hello All
    Sorry this one's a bit long
    Have come here after some testing !!

    I am trying to run Tuxedo suite for RNASeq Analysis on AWS

    Post alignment using Tophat, I have recorded significant difference in size of "accepted_hits.bam" between runs on AWS (Amazon Web Services) and Local System

    Details
    Paired end FastQs
    Size - after Adapter and quality thresholding - 7 gigs (3.5 X 2)
    Human Sample

    AWS Instance
    15 cores - of - m4.16xlarge (64 cores/256 RAM)
    Time ~45 min
    Out put accepted_hits.bam ~100mb

    Local Server
    15 cores - of - 36 cores/256 RAM
    Time ~52 min
    Out put accepted_hits.bam ~1.2GB

    Questions
    Why such significant difference? reasons?

    One thread I found, which was somewhat related
    https://www.biostars.org/p/102874/

    As suggested in the above thread, I have tried running tophat, with same parameters and input files,
    on 1, 5, 10, 15, 20, 30 and 64 cores on local servers
    on 30 and 64 cores on AWS

    Interestingly, the size of "accepted_hits.bam" remained same (1.2 gb) till I reached 30 cores on local server (with specs mentioned above), and reduced (~120 mb) on 64 cores.
    On AWS, as said above, 30 and (later) 64 are giving out ~100 mb of accepted_hits.bam

    any input, suggestions and comments are welcome
    thank you for your time !!
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Sounds like a bug to me... maybe you should try a different version of Tophat. The number of cores should not affect the size of the output bam more than a tiny amount.

    Alternatively, you could try BBMap; it's faster than Tophat and produces correct output for any number of cores

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Yesterday, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 05:39 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 09-29-2026, 09:51 AM
    0 responses
    77 views
    0 reactions
    Last Post SEQadmin2  
    Working...